KYMR logo

Kymera Therapeutics, Inc. (KYMR) Cash From Operations

Annual CFO:

-$194.50M-$91.67M(-89.16%)
December 31, 2024

Summary

  • As of today, KYMR annual cash from operations is -$194.50 million, with the most recent change of -$91.67 million (-89.16%) on December 31, 2024.
  • During the last 3 years, KYMR annual cash from operations has fallen by -$65.56 million (-50.84%).
  • KYMR annual cash from operations is now -320.70% below its all-time high of $88.13 million, reached on December 31, 2020.

Performance

KYMR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

Quarterly CFO:

-$27.11M+$32.77M(+54.73%)
September 30, 2025

Summary

  • As of today, KYMR quarterly cash from operations is -$27.11 million, with the most recent change of +$32.77 million (+54.73%) on September 30, 2025.
  • Over the past year, KYMR quarterly cash from operations has increased by +$23.08 million (+45.99%).
  • KYMR quarterly cash from operations is now -120.59% below its all-time high of $131.67 million, reached on September 30, 2020.

Performance

KYMR Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

TTM CFO:

-$227.93M+$23.08M(+9.19%)
September 30, 2025

Summary

  • As of today, KYMR TTM cash from operations is -$227.93 million, with the most recent change of +$23.08 million (+9.19%) on September 30, 2025.
  • Over the past year, KYMR TTM cash from operations has dropped by -$103.26 million (-82.82%).
  • KYMR TTM cash from operations is now -334.02% below its all-time high of $97.40 million, reached on September 30, 2020.

Performance

KYMR TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

KYMR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-89.2%+46.0%-82.8%
3Y3 Years-50.8%+20.9%-50.0%
5Y5 Years-1186.3%-120.6%-334.0%

KYMR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-89.2%at low-437.0%+65.8%-131.5%+9.2%
5Y5-Year-320.7%at low-120.6%+65.8%-334.0%+9.2%
All-TimeAll-Time-320.7%at low-120.6%+65.8%-334.0%+9.2%

KYMR Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$27.11M(+54.7%)
-$227.93M(+9.2%)
Jun 2025
-
-$59.88M(+24.3%)
-$251.01M(-7.2%)
Mar 2025
-
-$79.15M(-28.1%)
-$234.06M(-20.3%)
Dec 2024
-$194.50M(-89.2%)
-$61.78M(-23.1%)
-$194.50M(-56.0%)
Sep 2024
-
-$50.19M(-16.9%)
-$124.67M(-17.5%)
Jun 2024
-
-$42.94M(-8.4%)
-$106.13M(-7.8%)
Mar 2024
-
-$39.59M(-592.1%)
-$98.45M(+4.3%)
Dec 2023
-$102.83M(+32.8%)
$8.04M(+125.4%)
-$102.83M(+31.6%)
Sep 2023
-
-$31.65M(+10.2%)
-$150.41M(+1.7%)
Jun 2023
-
-$35.26M(+19.8%)
-$153.03M(+2.4%)
Mar 2023
-
-$43.97M(-11.2%)
-$156.76M(-2.4%)
Dec 2022
-$153.09M
-$39.54M(-15.4%)
-$153.09M(-0.8%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$34.27M(+12.1%)
-$151.90M(+1.9%)
Jun 2022
-
-$38.98M(+3.3%)
-$154.89M(-5.8%)
Mar 2022
-
-$40.30M(-5.1%)
-$146.42M(-13.5%)
Dec 2021
-$128.95M(-246.3%)
-$38.35M(-2.9%)
-$128.95M(-16.5%)
Sep 2021
-
-$37.26M(-22.1%)
-$110.66M(-289.9%)
Jun 2021
-
-$30.51M(-33.7%)
$58.27M(-24.7%)
Mar 2021
-
-$22.82M(-13.7%)
$77.36M(-12.2%)
Dec 2020
$88.13M(+392.2%)
-$20.07M(-115.2%)
$88.13M(-9.5%)
Sep 2020
-
$131.67M(+1253.8%)
$97.40M(+384.2%)
Jun 2020
-
-$11.41M(+5.3%)
-$34.27M(-49.9%)
Mar 2020
-
-$12.06M(-11.6%)
-$22.86M(-111.6%)
Dec 2019
$17.91M(+200.2%)
-$10.80M
-$10.80M
Dec 2018
-$17.86M
-
-

FAQ

  • What is Kymera Therapeutics, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. annual cash from operations year-on-year change?
  • What is Kymera Therapeutics, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. quarterly cash from operations year-on-year change?
  • What is Kymera Therapeutics, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. TTM cash from operations year-on-year change?

What is Kymera Therapeutics, Inc. annual cash from operations?

The current annual cash from operations of KYMR is -$194.50M

What is the all-time high annual cash from operations for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high annual cash from operations is $88.13M

What is Kymera Therapeutics, Inc. annual cash from operations year-on-year change?

Over the past year, KYMR annual cash from operations has changed by -$91.67M (-89.16%)

What is Kymera Therapeutics, Inc. quarterly cash from operations?

The current quarterly cash from operations of KYMR is -$27.11M

What is the all-time high quarterly cash from operations for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high quarterly cash from operations is $131.67M

What is Kymera Therapeutics, Inc. quarterly cash from operations year-on-year change?

Over the past year, KYMR quarterly cash from operations has changed by +$23.08M (+45.99%)

What is Kymera Therapeutics, Inc. TTM cash from operations?

The current TTM cash from operations of KYMR is -$227.93M

What is the all-time high TTM cash from operations for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high TTM cash from operations is $97.40M

What is Kymera Therapeutics, Inc. TTM cash from operations year-on-year change?

Over the past year, KYMR TTM cash from operations has changed by -$103.26M (-82.82%)
On this page